Candriam Luxembourg S.C.A. »

Keros Therapeutics shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2023-12-31 $33M 819k 39.76
2023-09-30 $24M 741k 31.87
2023-06-30 $29M 721k 40.20
2023-03-31 $32M 745k 42.70
2022-12-31 $30M 626k 48.00
2022-09-30 $14M 362k 37.62
2022-06-30 $0 362k 0.00
2022-03-31 $23M 421k 54.38
2021-12-31 $14M 241k 58.51
2021-09-30 $9.5M 241k 39.56
2021-06-30 $4.3M 101k 42.47